Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Liabilities from Discontinued Operations (2016)

Lisata Therapeutics (LSTA) has disclosed Liabilities from Discontinued Operations for 3 consecutive years, with 10925052.0 as the latest value for Q4 2016.

  • For the quarter ending Q4 2016, Liabilities from Discontinued Operations changed N/A year-over-year to 10925052.0, compared with a TTM value of 10925052.0 through Dec 2016, changed N/A, and an annual FY2016 reading of 10925052.0, changed N/A over the prior year.
  • Liabilities from Discontinued Operations was 10925052.0 for Q4 2016 at Lisata Therapeutics, down from 39343867.0 in the prior quarter.
  • Across five years, Liabilities from Discontinued Operations topped out at 39343867.0 in Q3 2012 and bottomed at 10925052.0 in Q4 2016.